Viral vectors in gene therapy K Lundstrom Diseases 6 (2), 42, 2018 | 573 | 2018 |
A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat F Jenck, J Wichmann, FM Dautzenberg, JL Moreau, AM Ouagazzal, ... Proceedings of the National Academy of Sciences 97 (9), 4938-4943, 2000 | 346 | 2000 |
Ionic permeability of, and divalent cation effects on, two ATP‐gated cation channels (P2X receptors) expressed in mammalian cells. RJ Evans, C Lewis, C Virginio, K Lundstrom, G Buell, A Surprenant, ... The Journal of physiology 497 (2), 413-422, 1996 | 338 | 1996 |
Latest development in viral vectors for gene therapy K Lundstrom Trends in biotechnology 21 (3), 117-122, 2003 | 337 | 2003 |
Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. P Pollesello, M Ovaska, J Kaivola, C Tilgmann, K Lundström, N Kalkkinen, ... Journal of Biological Chemistry 269 (46), 28584-28590, 1994 | 312 | 1994 |
Proposed Schizophrenia-Related Gene Polymorphism: Expression of the Ser9Gly Mutant Human Dopamine D3Receptor with the Semliki Forest Virus System K Lundstrom, MP Turpin Biochemical and biophysical research communications 225 (3), 1068-1072, 1996 | 301 | 1996 |
Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures MU Ehrengruber, K Lundstrom, C Schweitzer, C Heuss, S Schlesinger, ... Proceedings of the National Academy of Sciences 96 (12), 7041-7046, 1999 | 210 | 1999 |
An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs K Lundstrom G protein-coupled receptors in drug discovery, 51-66, 2009 | 178 | 2009 |
Carbon-based nanomaterials: promising antiviral agents to combat COVID-19 in the microbial-resistant era Á Serrano-Aroca, K Takayama, A Tuñón-Molina, M Seyran, SS Hassan, ... ACS nano 15 (5), 8069-8086, 2021 | 175 | 2021 |
Viral and non-viral vectors in gene therapy: technology development and clinical trials K Lundstrom, T Boulikas Technology in cancer research & treatment 2 (5), 471-485, 2003 | 171 | 2003 |
The structural basis of accelerated host cell entry by SARS‐CoV‐2 M Seyran, K Takayama, VN Uversky, K Lundstrom, G Palù, SP Sherchan, ... The FEBS journal 288 (17), 5010-5020, 2021 | 167 | 2021 |
Latest development in drug discovery on G protein-coupled receptors K Lundstrom Current Protein and Peptide Science 7 (5), 465-470, 2006 | 165 | 2006 |
Structural genomics on membrane proteins: comparison of more than 100 GPCRs in 3 expression systems K Lundstrom, R Wagner, C Reinhart, A Desmyter, N Cherouati, T Magnin, ... Journal of structural and functional genomics 7, 77-91, 2006 | 163 | 2006 |
Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest Virus, adenovirus, adeno-associated virus, lentivirus, and measles virus MU Ehrengruber, S Hennou, H Büeler, HY Naim, N Déglon, K Lundstrom Molecular and Cellular Neuroscience 17 (5), 855-871, 2001 | 162 | 2001 |
Molecular cloning and characterization of rat liver catechol-O-methyltransferase M Salminen, K Lundström, C Tilgmann, R Savolainen, N Kalkkinen, ... Gene 93 (2), 241-247, 1990 | 149 | 1990 |
Structural genomics and drug discovery K Lundstrom Journal of cellular and molecular medicine 11 (2), 224-238, 2007 | 140 | 2007 |
Structural genomics for membrane proteins K Lundstrom Cellular and Molecular Life Sciences CMLS 63 (22), 2597-2607, 2006 | 126 | 2006 |
Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression K Lundstrom, A Abenavoli, A Malgaroli, MU Ehrengruber Molecular therapy 7 (2), 202-209, 2003 | 125 | 2003 |
Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins K Lundstrom Biochimica et Biophysica Acta (BBA)-Biomembranes 1610 (1), 90-96, 2003 | 120 | 2003 |
Structural genomics of GPCRs K Lundstrom TRENDS in Biotechnology 23 (2), 103-108, 2005 | 114 | 2005 |